| Pinnacle Health Center, Inc. | |
|
801 Pine St Ste 2, Sandpoint, ID 83864-1682 | |
| (208) 255-2925 | |
| Not Available |
| Full Name | Pinnacle Health Center, Inc. |
|---|---|
| Type | Facility |
| Speciality | Chiropractor |
| Location | 801 Pine St Ste 2, Sandpoint, Idaho |
| Accepts Medicare Assignments | Does not participate in Medicare Program. The facility may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1417047788 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 111N00000X | Chiropractor | (* (Not Available)) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Pinnacle Health Center, Inc. 801 Pine St Ste 2, Sandpoint, ID 83864-1682 Ph: (208) 255-2925 | Pinnacle Health Center, Inc. 801 Pine St Ste 2, Sandpoint, ID 83864-1682 Ph: (208) 255-2925 |
News Archive
Lower potassium levels in the blood may help explain why African-Americans are twice as likely to be diagnosed with type 2 diabetes as whites, according to a new study by Johns Hopkins researchers.
ShangPharma Corporation, a leading China-based pharmaceutical and biotechnology research and development outsourcing company, today announced that its wholly-owned contract research subsidiary, Shanghai ChemPartner, has signed an outsource research service agreement with Shenogen Pharma Group to develop therapeutic monoclonal antibodies targeting the ER-alpha 36 receptor for cancer treatment.
Portola Pharmaceuticals, Inc. today announced two oral presentations at the European Society of Cardiology (ESC) Congress 2009 in Barcelona, Spain, that will feature its investigational antiplatelet drug elinogrel, a P2Y12 ADP receptor antagonist that is currently in Phase II clinical development with Novartis, Portola's development and commercialization partner.
On Tuesday, the National Center for Genome Resources and Simbiot announced a strategic partnership to create new solutions for handling 'big data' in the genomics space.
BioMarin Pharmaceutical Inc. announced today that it has received orphan drug designation from the U.S. Food and Drug Administration (FDA) for BMN-701, a novel fusion of insulin-like growth factor 2 and alpha glucosidase (IGF2-GAA) in development for the treatment of Pompe disease. An investigational new drug application (IND) for BMN-701 has been submitted, investigational material has been manufactured and a Phase I/II study is expected to start in the first quarter of 2011.
› Verified 6 days ago
Dr. Hans Konrad Steidl, D.C. Chiropractor Medicare: Medicare Enrolled Practice Location: 1301 N Division Ave, Sandpoint, ID 83864 Phone: 208-265-0610 Fax: 208-265-9192 | |
Dr. Cameron Cory Van Den Berg, DC Chiropractor Medicare: Accepting Medicare Assignments Practice Location: 1013 Lake St Ste 102, Sandpoint, ID 83864 Phone: 208-263-2247 Fax: 208-263-2268 | |
Daryl W. Reoch, D.C. Chiropractor Medicare: Not Enrolled in Medicare Practice Location: 301 S Division Ave, Suite B, Sandpoint, ID 83864 Phone: 208-263-1661 | |
Ambridge Chiropractic Neurology Pc Chiropractor Medicare: Medicare Enrolled Practice Location: 1327 W Superior St Ste 103, Sandpoint, ID 83864 Phone: 208-946-5888 | |
Josie Saganski, DC Chiropractor Medicare: Not Enrolled in Medicare Practice Location: 231 N 3rd Ave Ste 108, Sandpoint, ID 83864 Phone: 208-219-5833 Fax: 208-219-5334 | |
Dr. William Stephen Mihin, D.C. Chiropractor Medicare: Medicare Enrolled Practice Location: 1207 Michigan St Ste B, Sandpoint, ID 83864 Phone: 208-265-2225 Fax: 208-265-2229 | |
North Idaho Spine Clinic Chiropractor Medicare: Not Enrolled in Medicare Practice Location: 710 Superior St, Suite B, Sandpoint, ID 83864 Phone: 208-265-2225 |